Page last updated: 2024-08-21

fluorobenzenes and AIDS-Associated Nephropathy

fluorobenzenes has been researched along with AIDS-Associated Nephropathy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Funderburg, NT; Hileman, CO; Longenecker, CT; McComsey, GA	1

Trials

1 trial(s) available for fluorobenzenes and AIDS-Associated Nephropathy

Article	Year
Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Oct-15, Volume: 59, Issue:8 Topics: Adult; AIDS-Associated Nephropathy; Anti-Retroviral Agents; Biomarkers; Cystatin C; Female; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Kidney; Kidney Function Tests; Male; Middle Aged; Placebos; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2014

Article

Year

Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Oct-15, Volume: 59, Issue:8

Topics: Adult; AIDS-Associated Nephropathy; Anti-Retroviral Agents; Biomarkers; Cystatin C; Female; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Kidney; Kidney Function Tests; Male; Middle Aged; Placebos; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome

2014